Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free
The purpose of the study is to pilot test a multi-modal smoking cessation and relapse prevention intervention with the lung cancer patient population and to obtain preliminary data on its feasibility.
Checked against the public recordLast updated Apr 6, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Prevention
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Interventions being studied
- Drug: Nicotine patch and lozenges; Behavioral: Telephone counseling sessions; Behavioral: Access to a web-based video; Behavioral: Florida Tobacco Quitline
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * 18 years of age or older * Smoked at least 100 cigarettes in lifetime * Current smoking (defined as self-report of any smoking, even a puff, in the past 30 days) * Diagnosis of lung cancer * Able to read and write English * Not currently enrolled in a smoking cessation program * Has a working telephone * Has a valid home address Exclusion Criteria: * Current use of tobacco cessation medications * Another household member enrolled in this study * Contraindication of nicotine patch, unless under the supervision of a physician as advised by project staff * Moffitt clinical trial participant at time of enrollment
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Moffitt Cancer CenterTampa, Florida
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 6, 2026. Always confirm current availability with the study team.